Source: Annual Congress 2006 - Clinical problems: miscellaneous
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. S. Haque, M. Naeem, S. A. Aziz, A. B. Zubari, M. Irfan, N. A. Rao, N. Salauddin, J. A. Khan, F. Shahabuddin, G. Akber (Karachi, Pakistan). Inhaler therapy in obstructive airways disease (OAD): prescription, compliance and technique. Eur Respir J 2006; 28: Suppl. 50, 435

Member's Comments

No comment yet.

Related content which might interest you: Audit of inhaled corticosteroid prescription in chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2010 - COPD: management Year: 2010 What is the optimal treatment strategy for chronic obstructive pulmonary disease exacerbations? Source: Eur Respir J 2002; 19: 928-935 Year: 2002 Formoterol turbuhaler is effective and safe as maintenance or maintenance plus reliever therapy in patients with chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2002; 20: Suppl. 38, 243s Year: 2002 Osteoporosis risk assessment in elderly male patients with COPD who use inhaled corticosteroids Source: Annual Congress 2006 - COPD therapy Year: 2006 Reproducibility of inhaler use and pulmonary drug deposition in COPD Source: International Congress 2016 – Pulmonary drug delivery Year: 2016 Efficacy and safety of budesonide/formoterol in the management of chronic obstructive pulmonary disease Source: Eur Respir J 2003; 21: 74-81 Year: 2003 Poor compliance with guidelines for prescription of long-term oxygen therapy (LTOT) in chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2010 - Palliative care, oxygen and community care for chronic lung disease Year: 2010 Use of maintenance medications in patients with insufficiently controlled obstructive airway disease (OAD): the Belgian control survey Source: Eur Respir J 2002; 20: Suppl. 38, 47s Year: 2002 The influence of inhalation device for bronchodilators on the results of therapy in primary care patients with bronchial asthma (BA) and chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2008 - Asthma control or asthma severity Year: 2008 Once-daily QVA149 improves dyspnoea, lung function and reduces rescue medication use in symptomatic patients with COPD using LAMA as prior medication: The BLAZE study Source: International Congress 2014 – Clinical trials of drugs and biomarkers for respiratory diseases Year: 2014 The efficacy of formoterol in patients with chronic obstructive pulmonary disease (COPD) is not influenced by concomitant corticosteroid use Source: Eur Respir J 2001; 18: Suppl. 33, 515s Year: 2001 Efficacy and safety of budesonide/formoterol in the management of chronic obstructive pulmonary disease. Source: Eur Respir J 2003; 21: 912 Year: 2003 NVA237, a once-daily anticholinergic, demonstrates sustained bronchodilation and is well tolerated in patients with reversible obstructive airways disease Source: Annual Congress 2006 - Recent advances in the treatment of COPD Year: 2006 Modern treatment of chronic obstructive pulmonary disease Source: Eur Respir J 2001; 18: 60S-66S Year: 2001 Formoterol turbuhaler is an effective maintenance and maintenance plus reliever therapy in patients with chronic obstructive pulmonary disease (COPD) irrespective of the level of lung function impairment and reversibility Source: Eur Respir J 2002; 20: Suppl. 38, 243s Year: 2002 Patient needs and medication styles in COPD Source: Eur Respir Rev 2005; 14: 89-92 Year: 2005 Inhaled maintenance therapy and risk of first or subsequent emergency department visit/hospitalization in patients with COPD Source: Annual Congress 2006 - COPD therapy Year: 2006 Triple therapy with Fluticasone furoate/Umeclidinium/Vilanterol compared with dual bronchodilation or triple therapy with inhaled corticosteroids/dual bronchodilation in patients with chronic obstructive pulmonary disease Source: Virtual Congress 2020 – Investigations of COPD Year: 2020 Aerosolotherapy in stable chronic obstructive pulmonary disease (COPD) – common inhalers use ability and usefulness of PIF measurement in choice of inhalers Source: Annual Congress 2007 - Managing COPD in primary care Year: 2007 Bronchodilator responsiveness in patients with COPD Source: Eur Respir J 2008; 31: 742-750 Year: 2008